Your browser doesn't support javascript.
loading
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
Zhao, Shuang G; Lehrer, Jonathan; Chang, S Laura; Das, Rajdeep; Erho, Nicholas; Liu, Yang; Sjöström, Martin; Den, Robert B; Freedland, Stephen J; Klein, Eric A; Karnes, R Jeffrey; Schaeffer, Edward M; Xu, Melody; Speers, Corey; Nguyen, Paul L; Ross, Ashley E; Chan, June M; Cooperberg, Matthew R; Carroll, Peter R; Davicioni, Elai; Fong, Lawrence; Spratt, Daniel E; Feng, Felix Y.
Afiliação
  • Zhao SG; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI.
  • Lehrer J; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Chang SL; Department of Radiation Oncology, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Das R; Department of Radiation Oncology, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Erho N; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Liu Y; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Sjöström M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.
  • Den RB; Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Freedland SJ; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
  • Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN.
  • Schaeffer EM; Department of Urology, Northwestern University, IL.
  • Xu M; Department of Radiation Oncology, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Speers C; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI.
  • Nguyen PL; Dana-Farber/Brigham and Women's Cancer Center, Department of Radiation Oncology, Harvard Medical School, Boston, MA.
  • Ross AE; James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
  • Chan JM; Department of Urology, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Cooperberg MR; Department of Epidemiology & Biostatistics, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Carroll PR; Department of Urology, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Davicioni E; Department of Urology, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Fong L; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Spratt DE; Department of Medicine, Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA.
  • Feng FY; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI.
J Natl Cancer Inst ; 111(3): 301-310, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30321406
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno B7-H1 / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno B7-H1 / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2019 Tipo de documento: Article